MedTrace Logo

Preoperative Administration of Lugols Solution in Toxic Thyroid Diseases (TD): A Prospective Study

NCT06176976 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-12-20

No results posted yet for this study

Summary

Lugol's solution and other preparations containing iodide have been used as an adjuvant treatment in patients with toxic disease planned for thyroidectomy. However, no conclusive evidence supporting the benefits of preoperative treatment with LS for patients with toxic goiters. This trial aims to provide new insights into future recommendations.

Conditions

  • Toxic; Thyroid

Interventions

DIETARY_SUPPLEMENT

Lugol's iodine solution 5%

4 drops of LS every 8 hours for 10 days preoperatively will be given

Sponsors & Collaborators

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Styliani Laskou · 3rd Surgical Department of Aristotle University, AHEPA University Hospital, Thessaloniki

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2025-01-31
Completion
2025-06-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06176976 on ClinicalTrials.gov